-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - However, because the actual benefit each participant
experiences lies somewhere along a distribution … Conversely, most psychosocial trials provided too little
information on the participant characteristics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
September 01, 2011 - Nonrandomized trial 1 12
Prospective cohort 2 13,14
Retrospective cohort 7 15-21
Case series 2 22,23
Participant … and one RCT reported outcomes related
to the pump device.11,22,23 In a case series of 51 women,
one participant … Setting All studies were from the United States and participant data were acquired from a
national database … Bias: A systematic error, arising from participant
selection or outcome measurement that produces an
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-update-draft-report.pdf
October 01, 2022 - accidents (3%); 51 percent
allowed a mix of trauma types and 16 percent did not provide information on
participant … about half of studies
allowed a mix of trauma types (54%); 28 percent did not provide information on
participant … traumatic brain injuries, SUD, or suicidal ideation/behavior, and mean number of trauma types
per participant … additions could include
reporting outcomes for PTSD symptom clusters, item-level data, individual participant-level … data, subgroup analyses (e.g., to provide data on what works for whom), participant populations
with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - Mean number of trauma types and traumatic events experienced per participant
Study Interventions
1
-
effectivehealthcare.ahrq.gov/sites/default/files/transcript_deliberativemethodswebinar.pdf
April 19, 2012 - 1
AHRQ’s Community Forum
Using Deliberative Methods to Engage the Public
Webinar
Moderator: Jill Yegian
April 19, 2012
3:00 p.m. ET
[START]
Introduction
JILL YEGIAN: Thank you for joining us for this webinar on
using deliberative methods to engage the public. I’m Jill
YEGIAN with AHRQ’s Co…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-executive-170505.pdf
May 01, 2017 - University Arthritis Index [WOMAC] pain measures), as
two tools used in the same study on the same participant … We rated applicability of
participant populations and interventions separately, as
described below. … The most prevalent limit to study quality was participant
blinding: Only 33 of 85 RCTs reported an attempt … sufficient numbers
of participants to enable prespecified subgroup analysis
according to important participant … of the trials included in our review
modified interventions based on an assessment of
individual participant
-
effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
May 01, 2017 - University Arthritis Index [WOMAC] pain measures), as
two tools used in the same study on the same participant … We rated applicability of
participant populations and interventions separately, as
described below. … The most prevalent limit to study quality was participant
blinding: Only 33 of 85 RCTs reported an attempt … sufficient numbers
of participants to enable prespecified subgroup analysis
according to important participant … of the trials included in our review
modified interventions based on an assessment of
individual participant
-
effectivehealthcare.ahrq.gov/sites/default/files/hesse.pdf
January 01, 2010 - Hesse
Slide 1: Collaborating
for Health: Engaging
Community Intelligence for Better
Patient
Outcomes
Bradford W. Hesse,
Ph.D.
Chief, Health Communication and Informatics Research Branch
National Cancer
Institute,
Rockville,
MD
Slide 2: Emergence of the…
-
effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
November 11, 2015 - This is why you
do pilots…I had
a participant who talking aloud, clearly did
not understand
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_research.pdf
February 01, 2013 - Knowledge Brief #1 Public Deliberation on Health Topics
Community Forum Knowledge Brief
Number 1: Public Deliberation on Health Topics
AHRQ’s Effective Health Care Program
and the Community Forum
The Effective Health Care Program was initiated
in 2005 to provide valid evidence about the
comparative effect…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - We will
evaluate clinical and methodological heterogeneity by examining potential variations in participant
-
effectivehealthcare.ahrq.gov/products/deliberative-methods/presentation
June 13, 2013 - Using Deliberative Methods to Engage the Public - Facilitating a Deliberative Session (Audio Presentation)
Presentation June 13, 2013
This webinar provides practical guidance on facilitating deliberative sessions. Public deliberation convenes members of the public to learn about and discuss a complex so…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
April 01, 2012 - glaucoma at the time of
screening (KQs 1, 2, 4, and 5) and those that included the
healthy eye of a participant
-
effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
June 23, 2014 - control characteristics (intervention components, timing, frequency, duration), followup duration, participant … Item Bank. 14 We selected items most relevant in assessing risk of bias for this topic, including participant … source indicated
Medical record, only ICD9 or other summary statement, lacks detail
Interview with participant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
September 20, 2013 - able to be abstracted from data in the papers
Data must be presented in the aggregate (vs. individual participant … We anticipate that these data will include those related to baseline
participant characteristics (age … This quality-
assessment approach considered factors related to study design, diagnostic approach, participant
-
effectivehealthcare.ahrq.gov/sites/default/files/manges.pdf
January 06, 2017 - ENVIRONMENTAL PROTECTION AGENCY
INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY
SPEAKER: ELLEN MANGES,
SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER)
ENVIRONMENTAL PROTECTION AGENCY (EPA)
MANGES: My name is Ellen Manges. I'm a senior advisor. I…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-3-appendix-h-table-h-1.xlsx
January 01, 2021 - H-1. RoB 2 Assessment
Table H-1. Risk of Bias 2 Assessment of New Included Studies
RoB Domain Bias due to randomization (Cochrane) or Selection bias (AHRQ); Randomization Bias due to randomization (Cochrane) or Selection bias (AHRQ); Allocation Bias due to randomization (Cochrane) or Selection bias (AHRQ); Similarit…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-update-appendix-g-table-g-1.xlsx
January 01, 2022 - G-1. RoB 2 Assessment PTSD4
Table G-1. Risk of Bias 2 assessment of new included studies
RoB Domain Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Randomization Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Allocation Bias Due to Randomization (Cochrane) or Selection Bias (AHRQ); Simi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - and exclusion criteria,
intervention and control characteristics, sample size, follow-up duration, participant … bias of
eligible RCTs will be assessed using the Cochrane Risk of Bias Tool.14 Components
include participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
November 28, 2023 - Evaluation of Dietary Protein Intake Requirements
Evidence-Based Practice Center Systematic Review Protocol
Project Title: Evaluation of Dietary Protein Intake Requirements
Publication Date: June 2, 2023
Amendment Date(s): November 17, 2023, November 28, 2023
(Amendments Details–see Section VI)
I. B…